Search

everythinglearnresearchcommunity

for

Search:↓

Intravenous calcium therapy is a safe and effective treatment for a rare type of rickets.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

Hair loss can occur as a side effect of certain breast cancer treatments, but minoxidil can help regrow hair.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Abrocitinib may effectively treat stubborn alopecia universalis.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Talquetamab may cause hair loss and skin issues.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

The drug combination was safe and showed promise in treating advanced tumors.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.